{
    "code": "02019276",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019276",
    "time": "2020-02-25 12:09:03",
    "許可證字號": "衛署藥輸字第019276號",
    "註銷狀態": "已註銷",
    "註銷日期": "96\/06\/28",
    "註銷理由": "未展延而逾期者",
    "有效日期": "89\/02\/01",
    "發證日期": "81\/05\/26",
    "許可證種類": "製　劑",
    "舊證字號": "02009760",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201927607",
    "中文品名": "羅舒咳膠囊５００公絲",
    "英文品名": "LOVISCOL CAPSULES 500MG",
    "適應症": "減少呼吸道粘膜分泌的粘稠性",
    "劑型": "130膠囊劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司臺灣分公司",
        "申請商地址": "台北巿健康路156號8樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800000600",
            "成分名稱": "CARBOCYSTEINE (S-CARBOXYMETHYL CYSTEINE)",
            "含量描述": "500.00",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ]
}